Login
Search The Defender
Search Results for "moderna"
09/04/25Moderna and Novavax Respond to Trump’s Demands for COVID Vaccine Evidence + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
08/26/25Moderna Stock Falls, Pfizer Dips on COVID Vaccine Ban Speculation + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
07/10/25‘Concerning and Bewildering’: FDA Grants Full Approval of Moderna COVID Vaccine for ‘At-Risk’ Infants and Children
Critics questioned the decision, citing a lack of safety data, a long list of serious adverse events and the low risk COVID-19 poses to children. “I haven’t seen any data related to the use of this injection in the pediatric population,” said Dr. Larry Palevsky, a pediatrician.
07/09/25Lawyer Leading Lawsuit Against RFK Jr. Over COVID Vaccines Used to Work for Moderna
Richard Henry Hughes IV, a former vice president at Moderna, is the lead lawyer representing the plaintiffs suing Health Secretary Robert F. Kennedy Jr. and several other public health officials and agencies over recent changes to COVID-19 vaccine recommendations for children and pregnant women.
06/12/25‘People Inside Moderna Are Afraid’: As Anti-Vaccine Climate Intensifies, the Company Has Much to Lose + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
06/03/25FDA Approves New Moderna COVID Vaccine — Clinical Trials Show It Causes Serious Adverse Events in 2.7% of Recipients
Medical commentator John Campbell, Ph.D., said it’s “bemusing” that the FDA could authorize a vaccine with such high risk and limited efficacy. The vaccine, mNEXSPIKE, uses the newer self-amplifying mRNA technology.
05/29/25U.S. Cancels Contracts Worth $766 Million for Moderna Bird Flu Vaccine After ‘Rigorous Review’
An HHS spokesperson confirmed the news today, telling The Defender the vaccine was found not to be “scientifically or ethically justifiable,” after clinical trials identified safety and efficacy concerns.
05/22/25Pfizer, Moderna Must Add Stronger Warnings About Possible Heart Damage From COVID Vaccines, FDA Says
The vaccine makers must expand information about the age groups at risk and warn that myocardial damage has commonly been long-lasting among those who suffer vaccine-related myocarditis, the FDA said Wednesday.
05/21/25Moderna Pulls Application for FDA Approval of Flu-COVID Shot After FDA Calls for New Clinical Trials
According to Reuters, Moderna’s decision to withdraw its application at this time “is the latest sign of increased regulatory scrutiny of the vaccine approval process since Robert F. Kennedy Jr. took the top U.S. health job earlier this year.”
05/06/25Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
05/05/25Pfizer Vaccine Linked to Higher All-Cause Mortality Rate Than Moderna Shot
People who received two doses of Pfizer’s COVID-19 vaccine were more likely to die within a year from cardiac arrest, COVID-19 and all other causes than those who received two doses of Moderna’s vaccine, according to the authors of a study published April 29 on the preprint server medRxiv.
04/30/25HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
04/28/25Moderna in Trouble in UK for Offering Kids Money and Teddy Bears to Participate in COVID Vaccine Trials
Pharma giant Moderna faces suspension or expulsion from a U.K. trade group for breaking several industry rules, including offering children teddy bears and large payments to participate in COVID-19 trials, The Telegraph reported.
01/17/25Watch: Journalist Alex Berenson on FDA Failure to Report Death of Young Child in Moderna Trials
Alex Berenson, a former New York Times reporter, said Moderna disclosed the death only to European regulators. The FDA, which likely learned of the child’s death later but never publicly shared the information, has provided only vague responses to Berenson’s inquiries about the death.
01/08/25Moderna Covered Up Death, Injuries in COVID Vaccine Trials. Will Trump Hold the Company Accountable?
Pharmaceutical companies have remained largely immune for their role in perpetrating global-scale deception resulting in thousands of vaccine injuries and billions in profits. The next administration must hold the vaccine maker accountable.
01/06/25A Young Child Died During Moderna COVID Vaccine Clinical Trial — Did FDA Know?
A preschool-aged child died of cardio-respiratory arrest after getting a COVID-19 booster in a Moderna clinical trial, according to an investigation by journalist Alex Berenson. The FDA has yet to answer the question: Did the agency know about the death?
12/18/24Australia Inks $2 Billion Deal Allowing Moderna mRNA Vaccines to Bypass ‘Key Step’ in Safety Process
Under a confidential deal signed by Australia’s former prime minister, Moderna mRNA vaccines produced at the company’s new Australian facility won’t have to undergo an assessment by the country’s independent advisory committee.
12/13/24FDA Advisers Bullish on RSV Shots for Kids, Even as Safety Signals Shut Down Moderna Trials
Vaccine makers are developing 26 different RSV vaccines or monoclonal antibodies for all age groups, as they vie for a slice of the rapidly expanding market. Discussions during Thursday’s FDA vaccine advisory committee focused on the “unmet need” for more RSV shots for infants and toddlers and how to move them forward.
12/11/24Moderna Shuts Down mRNA RSV Vaccine Trial in Babies After Shots Linked to Severe Side Effects, FDA Document Reveals
The FDA’s vaccine advisory committee will meet tomorrow to discuss concerns about the vaccine, which the agency fast-tracked in 2021. Meanwhile, trials for investigational RSV vaccines for babies and some children are now on hold.
10/28/24Pfizer, Moderna mRNA COVID Shots Linked to Higher Risk of Acute Heart Disease
The South Korean authors of a peer-reviewed study published Oct. 24 in Epidemiology and Infection said the heightened risk was most pronounced among people ages 10 to 59 compared with those age 60 and older.
10/17/24‘Reckless Disregard for the Truth’: Shareholders Sue Moderna for Misleading Investors on RSV Shot Efficacy
A class-action lawsuit filed in August accuses Moderna of making “materially false and misleading statements” about the efficacy of its RSV shot, leading to significant damages for investors.
09/26/24Moderna Is Scolded by a U.K. Trade Group for Offering Kids $2,000 to Participate in a Covid Trial + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
08/06/24Moderna Is Still in a COVID Hangover + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
08/01/24Moderna Shares Fall Amid Lower Sales Outlook for RSV, COVID Shots + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
07/29/24Merck Unveils New RSV Shot for Babies, as Moderna Trials mRNA RSV Vaccine for Infants and Toddlers
As the market for RSV shots booms, Merck announced a new monoclonal antibody shot with “positive” results in infants, while Moderna called for more participants in its mRNA RSV vaccine trial by posting on Instagram a picture of the first baby to receive the experimental vaccine.
07/17/24Moderna COVID Vaccines More Deadly Than Pfizer’s? Maybe, Analysis Shows
The Moderna COVID-19 vaccine was linked to significantly higher mortality rates than the Pfizer vaccines, based on a preliminary analysis of individual health data for the Czech Republic. Scientists call for more research.
07/02/24Bird Flu Concern Prompts U.S. to Award Moderna $176 Million for Vaccine Development + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
06/18/24Moderna Stock Is Lone Omen of Bird Flu Pandemic + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
06/03/24FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers
The FDA said it bypassed input from the agency’s independent advisers because it didn’t see any “concerns or controversial issues.” Moderna is running at least 11 clinical trials for its new mRNA RSV drug on other demographic groups, including young children, adolescents and healthy adults.
05/31/24FDA Approves Moderna’s RSV Vaccine for Seniors, the Company’s Second-Ever Product + More
The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.